ACN Newswire

Thu Jun 7

NANOBIOTIX' Management Statement on Recent Share Price Variation

Written by ACN Newswire

Paris, France and Cambridge, Massachusetts, USA, Jun 6, 2018 - (ACN Newswire) - NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, communicates today regarding the recent evolution of its share price.

The Company noticed a significant decrease of its...

ACN Newswire

NANOBIOTIX' Management Statement on Recent Share Price Variation

Grattan on Friday: Is Barnaby's baby a matter of public interest or just of interest to the public?

Reduce Your Plastic Consumption With These Simple Steps

What kind of state values a freeway's heritage above the heritage of our oldest living culture?

Head On Festival review: every photograph tells a virtual story

If you're feeding with formula, here's what you can do to promote your baby's healthy growth

Holographic teachers were supposed to be part of our future. What happened?

Three charts on: why rates of mental illness aren't going down despite higher spending

Coronavirus: what causes a 'second wave' of disease outbreak, and could we see this in Australia?

Why falling house prices do less to improve affordability than you might think

Ice melt in Greenland and Antarctica predicted to bring more frequent extreme weather

Spruiking the stars: some home builders are misleading consumers about energy ratings